Search

Your search keyword '"Lythgoe, H."' showing total 88 results
Start Over Author "Lythgoe, H."
88 results on '"Lythgoe, H."'

2. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design : An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

Author

Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., Jacobs, B., Vasileiou, D., Wadsworth, I., Ambrose, N., Davidson, J., Ferguson, P. J., Herlin, T., Kavirayani, A., Killeen, O. G., Compeyrot-Lacassagne, S., Laxer, R. M., Roderick, M., Swart, J. F., Hedrich, C. M., Beresford, M. W., Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., Jacobs, B., Vasileiou, D., Wadsworth, I., Ambrose, N., Davidson, J., Ferguson, P. J., Herlin, T., Kavirayani, A., Killeen, O. G., Compeyrot-Lacassagne, S., Laxer, R. M., Roderick, M., Swart, J. F., Hedrich, C. M., and Beresford, M. W.

Published
2019

3. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

Author

Apotheek Opleiding, Immuno/reuma patientenzorg, Child Health, Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., Jacobs, B., Vasileiou, D., Wadsworth, I., Ambrose, N., Davidson, J., Ferguson, P. J., Herlin, T., Kavirayani, A., Killeen, O. G., Compeyrot-Lacassagne, S., Laxer, R. M., Roderick, M., Swart, J. F., Hedrich, C. M., Beresford, M. W., Apotheek Opleiding, Immuno/reuma patientenzorg, Child Health, Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., Jacobs, B., Vasileiou, D., Wadsworth, I., Ambrose, N., Davidson, J., Ferguson, P. J., Herlin, T., Kavirayani, A., Killeen, O. G., Compeyrot-Lacassagne, S., Laxer, R. M., Roderick, M., Swart, J. F., Hedrich, C. M., and Beresford, M. W.

Published
2019

5. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

Author

Ramanan, A. V., primary, Hampson, L. V., additional, Lythgoe, H, additional, Jones, A. P., additional, Hardwick, B, additional, Hind, H, additional, Jacobs, B, additional, Vasileiou, D, additional, Wadsworth, I, additional, Ambrose, N, additional, Davidson, J, additional, Ferguson, P. J., additional, Herlin, T, additional, Kavirayani, A, additional, Killeen, O. G., additional, Compeyrot-Lacassagne, S, additional, Laxer, R. M., additional, Roderick, M, additional, Swart, J. F., additional, Hedrich, C. M., additional, and Beresford, M. W., additional

Published
2019
Full Text
View/download PDF

6. Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis

Author

Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O, Al-Abadi, E, Armon, K, Bailey, K, Davidson, J, Friswell, M, Gardner-Medwin, J, Haslam, K, Ioannou, Y, Leahy, A, Leone, V, Pilkington, C, Rangaraj, S, Riley, P, Tizard, EJ, Wilkinson, N, Beresford, MW, and Grp, UKJSLE Study

Subjects
Male, medicine.medical_specialty, Pediatrics, Adolescent, National cohort, Disease course, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Humans, Lupus Erythematosus, Systemic, 030212 general & internal medicine, Longitudinal Studies, Stage (cooking), Age of Onset, Child, 030203 arthritis & rheumatology, business.industry, Clinical trial, Juvenile onset, Child, Preschool, Physical therapy, Observational study, Female, business, Cohort study, Follow-Up Studies
Abstract

Objectives The Systemic Lupus International Collaborating Clinics (SLICC) group proposed revised classification criteria for systemic lupus erythematosus (SLICC-2012 criteria). This study aimed to compare these criteria with the well-established American College of Rheumatology classification criteria (ACR-1997 criteria) in a national cohort of juvenile-onset systemic lupus erythematosus (JSLE) patients and evaluate how patients’ classification criteria evolved over time. Methods Data from patients in the UK JSLE Cohort Study with a senior clinician diagnosis of probable evolving, or definite JSLE, were analyzed. Patients were assessed using both classification criteria within 1 year of diagnosis and at latest follow up (following a minimum 12-month follow-up period). Results A total of 226 patients were included. The SLICC-2012 was more sensitive than ACR-1997 at diagnosis (92.9% versus 84.1% p Conclusions The SLICC-2012 was better able to classify patients with JSLE than the ACR-1997 and did so at an earlier stage in their disease course. SLICC-2012 should be considered for classification of JSLE patients in observational studies and clinical trial eligibility.

Published
2017

11. Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis

Author

Lythgoe, H, primary, Morgan, T, additional, Heaf, E, additional, Lloyd, O, additional, Al-Abadi, E, additional, Armon, K, additional, Bailey, K, additional, Davidson, J, additional, Friswell, M, additional, Gardner-Medwin, J, additional, Haslam, K, additional, Ioannou, Y, additional, Leahy, A, additional, Leone, V, additional, Pilkington, C, additional, Rangaraj, S, additional, Riley, P, additional, Tizard, E J, additional, Wilkinson, N, additional, and Beresford, M W, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results